Search

Your search keyword '"Adams, Ortwin"' showing total 518 results

Search Constraints

Start Over You searched for: Author "Adams, Ortwin" Remove constraint Author: "Adams, Ortwin"
518 results on '"Adams, Ortwin"'

Search Results

51. Association of viral load with TRAIL, IP‐10, CRP biomarker signature and disease severity in children with respiratory tract infection or fever without source: A prospective, multicentre cohort study.

52. Design of D-amino acids SARS-CoV-2 Main protease inhibitors using the cationic peptide from rattlesnake venom as a scaffold

54. Induction of trained immunity by influenza vaccination - impact on COVID-19

56. SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response

57. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients

58. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany

63. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

66. Association of HLA and Mutated CCR5 With the Clinical Course of the Disease in Subjects With mild / moderate disease following COVID-19 infection

69. Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2

70. Type O blood group associates with higher anti-JC polyomavirus antibody levels

71. SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response

75. Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy

76. The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses

77. Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft Failure

78. Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

79. Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination

80. Screening for SARS-CoV-2 infections in daycare facilities for children in a large city in Germany

82. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission

83. Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin-2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome

84. A Pan-respiratory Antiviral Chemotype Targeting a Transient Host Multiprotein Complex

85. PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy

89. Humoral response to SARS‐CoV‐2 and seasonal coronaviruses in COVID‐19 patients.

95. Sensitivity of commercial Anti-SARS-CoV-2 serological assays in a high-prevalence setting

96. Genetic structure of SARS-CoV-2 reflects clonal superspreading and multiple independent introduction events, North-Rhine Westphalia, Germany, February and March 2020

98. SARS-CoV-2 targets cortical neurons of 3D human brain organoids and shows neurodegeneration-like effects

99. Genetic structure of SARS-CoV-2 in Western Germany reflects clonal superspreading and multiple independent introduction events

Catalog

Books, media, physical & digital resources